The Children’s Tumor Foundation (CTF) is supporting the addition of a new treatment arm to the INTUITT-NF2 platform clinical trial, an innovative clinical trial designed to accelerate the development of therapies for people living with NF2-related schwannomatosis (NF2-SWN).
This new arm will evaluate a combination of retifanlimab and bevac...